Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical Trial

Introduction: Currently, using various combinations of narcotic and analgesic drugs has received attention for induction of sedation and analgesia due to their synergy in controlling pain and anxiety. The present study was designed with the aim of comparing dexmedetomidine-fentanyl combination with...

Full description

Bibliographic Details
Main Authors: Ali Arhami-Dolatabadi, Elham Memary, Majid Shojaee, Hossein Kamalifard
Format: Article
Language:English
Published: Shahid Beheshti University of Medical Sciences 2018-11-01
Series:Archives of Academic Emergency Medicine
Subjects:
Online Access:https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/53
_version_ 1818042798137409536
author Ali Arhami-Dolatabadi
Elham Memary
Majid Shojaee
Hossein Kamalifard
author_facet Ali Arhami-Dolatabadi
Elham Memary
Majid Shojaee
Hossein Kamalifard
author_sort Ali Arhami-Dolatabadi
collection DOAJ
description Introduction: Currently, using various combinations of narcotic and analgesic drugs has received attention for induction of sedation and analgesia due to their synergy in controlling pain and anxiety. The present study was designed with the aim of comparing dexmedetomidine-fentanyl combination with midazolam-fentanyl in this regard. Methods: In this randomized clinical trial, patients diagnosed with distal radius fracture who had visited the emergency department (ED) were allocated to either the group receiving the combination of fentanyl-midazolam or the one receiving dexmedetomidine-fentanyl for procedural sedation and analgesia (PSA) and were compared regarding analgesic characteristics, time to recovery and side effects. Results: 80 patients with the mean age of 42.08 ± 12.17 (18 - 60) years were randomly allocated to 2 groups of 40 (83.80% male). The 2 groups did not have a significant difference regarding baseline characteristics as well as pain severity.  Mean pain score at the time of procedure was 3.47 ± 1.37 in dexmedetomidine and 2.85 ± 1.05 in midazolam group (p = 0.025). In addition, time to recovery in dexmedetomidine and midazolam groups was 6.60 ± 1.86 minutes and 12.70 ± 1.70 minutes, respectively (p < 0.001). Out of the 9 patients who experienced treatment failure, 8 (88.90%) patients were in dexmedetomidine group and 1 (11.10%) was in midazolam group (p = 0.029). Absolute risk increase rate of treatment failure in case of using dexmedetomidine instead of midazolam was 17.50% (95%CI: 4.19 – 30.81) and number needed to harm was 6.00 (95% CI: 3.20 – 23.80). Conclusion: Although the combination of dexmedetomidine-fentanyl had a shorter time to recovery compared to midazolam-fentanyl for induction of sedation and analgesia, the treatment failure rate in case of using dexmedetomidine with 1 µg/kg increased 17.5% and about 1 out of each 6 patients needed a rescue dose.
first_indexed 2024-12-10T08:52:02Z
format Article
id doaj.art-a58d5911dcbe4f59a56b0b8d874927bc
institution Directory Open Access Journal
issn 2645-4904
language English
last_indexed 2024-12-10T08:52:02Z
publishDate 2018-11-01
publisher Shahid Beheshti University of Medical Sciences
record_format Article
series Archives of Academic Emergency Medicine
spelling doaj.art-a58d5911dcbe4f59a56b0b8d874927bc2022-12-22T01:55:33ZengShahid Beheshti University of Medical SciencesArchives of Academic Emergency Medicine2645-49042018-11-016110.22037/aaem.v6i1.53Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical TrialAli Arhami-Dolatabadi0Elham Memary1Majid Shojaee2Hossein Kamalifard3Emergency Department, Imam Hossein Hospital, Shahid Beheshti University Of Medical Sciences, Tehran, Iran.Anesthesiology Department, Imam Hossein Hospital, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Emergency Department, Imam Hossein Hospital, Shahid Beheshti University Of Medical Sciences, Tehran, Iran.Emergency Department, Imam Hossein Hospital, Shahid Beheshti University Of Medical Sciences, Tehran, Iran.Introduction: Currently, using various combinations of narcotic and analgesic drugs has received attention for induction of sedation and analgesia due to their synergy in controlling pain and anxiety. The present study was designed with the aim of comparing dexmedetomidine-fentanyl combination with midazolam-fentanyl in this regard. Methods: In this randomized clinical trial, patients diagnosed with distal radius fracture who had visited the emergency department (ED) were allocated to either the group receiving the combination of fentanyl-midazolam or the one receiving dexmedetomidine-fentanyl for procedural sedation and analgesia (PSA) and were compared regarding analgesic characteristics, time to recovery and side effects. Results: 80 patients with the mean age of 42.08 ± 12.17 (18 - 60) years were randomly allocated to 2 groups of 40 (83.80% male). The 2 groups did not have a significant difference regarding baseline characteristics as well as pain severity.  Mean pain score at the time of procedure was 3.47 ± 1.37 in dexmedetomidine and 2.85 ± 1.05 in midazolam group (p = 0.025). In addition, time to recovery in dexmedetomidine and midazolam groups was 6.60 ± 1.86 minutes and 12.70 ± 1.70 minutes, respectively (p < 0.001). Out of the 9 patients who experienced treatment failure, 8 (88.90%) patients were in dexmedetomidine group and 1 (11.10%) was in midazolam group (p = 0.029). Absolute risk increase rate of treatment failure in case of using dexmedetomidine instead of midazolam was 17.50% (95%CI: 4.19 – 30.81) and number needed to harm was 6.00 (95% CI: 3.20 – 23.80). Conclusion: Although the combination of dexmedetomidine-fentanyl had a shorter time to recovery compared to midazolam-fentanyl for induction of sedation and analgesia, the treatment failure rate in case of using dexmedetomidine with 1 µg/kg increased 17.5% and about 1 out of each 6 patients needed a rescue dose.https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/53Conscious sedationanalgesiadexmedetomidinemidazolamclosed fracture reductionclinical trial
spellingShingle Ali Arhami-Dolatabadi
Elham Memary
Majid Shojaee
Hossein Kamalifard
Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical Trial
Archives of Academic Emergency Medicine
Conscious sedation
analgesia
dexmedetomidine
midazolam
closed fracture reduction
clinical trial
title Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical Trial
title_full Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical Trial
title_fullStr Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical Trial
title_full_unstemmed Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical Trial
title_short Dexmedetomidine-Fentanyl versus Midazolam-Fentanyl in Pain Management of Distal Radius Fractures Reduction; a Randomized Clinical Trial
title_sort dexmedetomidine fentanyl versus midazolam fentanyl in pain management of distal radius fractures reduction a randomized clinical trial
topic Conscious sedation
analgesia
dexmedetomidine
midazolam
closed fracture reduction
clinical trial
url https://journals.sbmu.ac.ir/aaem/index.php/AAEM/article/view/53
work_keys_str_mv AT aliarhamidolatabadi dexmedetomidinefentanylversusmidazolamfentanylinpainmanagementofdistalradiusfracturesreductionarandomizedclinicaltrial
AT elhammemary dexmedetomidinefentanylversusmidazolamfentanylinpainmanagementofdistalradiusfracturesreductionarandomizedclinicaltrial
AT majidshojaee dexmedetomidinefentanylversusmidazolamfentanylinpainmanagementofdistalradiusfracturesreductionarandomizedclinicaltrial
AT hosseinkamalifard dexmedetomidinefentanylversusmidazolamfentanylinpainmanagementofdistalradiusfracturesreductionarandomizedclinicaltrial